Side effects, images, and drug details for Tibsovo - Inside Rx
Back to Search Results

Tibsovo

ivosidenib
Ivosidenib targets a specific gene mutation called IDH1, which can affect your bone marrow. IDH1 mutation prevents young blood cells from developing into healthy adult blood cells, which can result in symptoms of acute myeloid leukemia (AML). Ivosidenib is used to treat AML in adults with an IDH1 mutation. Your doctor will test you for this gene. Ivosidenib is used when other treatments did not work or have stopped working. Ivosidenib is also used in adults 75 years and older who have newly-diagnosed AML and cannot use certain chemotherapy treatments because of other health problems. Ivosidenib may also be used for purposes not listed in this medication guide.
CHEMICAL NAME
ivosidenib
DRUG TYPE
miscellaneous antineoplastics
Rx icon

Learn more about price differences between brand and generic drugs

Get the Inside Rx app

Frequently Asked Questions

Ivosidenib can cause a condition called differentiation syndrome, which affects blood cells and can be fatal if not treated. This condition may occur within 1 days to 3 months after you start taking ivosidenib.

Seek medical help right away if you have symptoms of differentiation syndrome: fever, dizziness, cough, trouble breathing, swelling, rapid weight gain, rash, or decreased urination.

Similar Drugs

Brand Name Examples Supplied As Strength
Tibsovo tablet 250 mg

Save up to 80% on brand & generic medications.